| 1 | BAY 63-2521 | - | - | - | - | [2] 86 86, 88 |
| 2 | BAY 63-2521 0.06 % | - | - | - | - | [1] 86 86 |
| 3 | BAY 63-2521 0.3 % | - | - | - | - | [1] 86 86 |
| 4 | BAY 63-2521 coated tablets 0.5 mg | - | - | - | - | [2] 86 86, 88 |
| 5 | BAY 63-2521 coated tablets 1 mg | - | - | - | - | [2] 86 86, 88 |
| 6 | BAY 63-2521 coated tablets 1.5 mg | - | - | - | - | [2] 86 86, 88 |
| 7 | BAY 63-2521 coated tablets 2 mg | - | - | - | - | [2] 86 86, 88 |
| 8 | BAY 63-2521 coated tablets 2.5 mg | - | - | - | - | [2] 86 86, 88 |
| 9 | BAY 63-2521 IR coated tablet 1.0 mg | - | - | - | - | [1] 88 88 |
| 10 | BAY 63-2521 IR coated tablet 1.5 mg | - | - | - | - | [1] 88 88 |
| 11 | BAY 63-2521 IR coated tablet 2.0 mg | - | - | - | - | [1] 88 88 |
| 12 | BAY 63-2521 IR coated tablet 2.5 mg | - | - | - | - | [1] 88 88 |
| 13 | BAY 63-2521 IR tablet 0.5 mg | - | - | - | - | [1] 88 88 |
| 14 | BAY 63-2521 IR tablet 1.0 mg | - | - | - | - | [1] 88 88 |
| 15 | BAY 63-2521 IR tablet 1.5 mg | - | - | - | - | [1] 88 88 |
| 16 | BAY 63-2521 IR tablet 2.0 mg | - | - | - | - | [1] 88 88 |
| 17 | BAY 63-2521 IR tablet 2.5 mg | - | - | - | - | [1] 88 88 |
| 18 | BAY 63-2521 IR tablets 0.5 mg | - | - | - | - | [1] 86 86 |
| 19 | BAY 63-2521 IR tablets 1 mg | - | - | - | - | [1] 86 86 |
| 20 | BAY 63-2521 IR tablets 1.0 mg | - | - | - | - | [1] 86 86 |
| 21 | BAY 63-2521 IR tablets 1.5 mg | - | - | - | - | [1] 86 86 |
| 22 | BAY 63-2521 IR tablets 2.0 mg | - | - | - | - | [1] 86 86 |
| 23 | BAY 63-2521 IR tablets 2.5 mg | - | - | - | - | [1] 86 86 |
| 24 | BAY 63-2521 Tablet | - | - | - | - | [1] 86 86 |
| 25 | BAY 63-2521 tablets 0.5 mg | - | - | - | - | [2] 86 86, 88 |
| 26 | BAY 63-2521 tablets 1 mg | - | - | - | - | [2] 86 86, 88 |
| 27 | BAY 63-2521 tablets 1.5 mg | - | - | - | - | [2] 86 86, 88 |
| 28 | BAY 63-2521 tablets 2 mg | - | - | - | - | [2] 86 86, 88 |
| 29 | BAY 63-2521 tablets 2.5 mg | - | - | - | - | [2] 86 86, 88 |